BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 16490755)

  • 1. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
    Harrison P; Pointon JJ; Farrar C; Brown MA; Wordsworth BP
    Rheumatology (Oxford); 2006 Aug; 45(8):1009-11. PubMed ID: 16490755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
    van Oene M; Wintle RF; Liu X; Yazdanpanah M; Gu X; Newman B; Kwan A; Johnson B; Owen J; Greer W; Mosher D; Maksymowych W; Keystone E; Rubin LA; Amos CI; Siminovitch KA
    Arthritis Rheum; 2005 Jul; 52(7):1993-8. PubMed ID: 15986374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.
    Lee AT; Li W; Liew A; Bombardier C; Weisman M; Massarotti EM; Kent J; Wolfe F; Begovich AB; Gregersen PK
    Genes Immun; 2005 Mar; 6(2):129-33. PubMed ID: 15674368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
    Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population.
    Wesoly J; Hu X; Thabet MM; Chang M; Uh H; Allaart CF; Toes RE; Houwing-Duistermaat JJ; Begovich AB; Huizinga TW
    Rheumatology (Oxford); 2007 Apr; 46(4):617-21. PubMed ID: 17135225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
    Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
    Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
    Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.
    Newman WG; Zhang Q; Liu X; Walker E; Ternan H; Owen J; Johnson B; Greer W; Mosher DP; Maksymowych WP; Bykerk VP; Keystone EC; Amos CI; Siminovitch KA
    Arthritis Rheum; 2006 Dec; 54(12):3820-7. PubMed ID: 17133579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma.
    Majorczyk E; Jasek M; Płoski R; Wagner M; Kosior A; Pawlik A; Obojski A; Luszczek W; Nowak I; Wiśniewski A; Kuśnierczyk P
    Eur J Hum Genet; 2007 Oct; 15(10):1043-8. PubMed ID: 17579671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
    Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
    Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
    Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
    Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients.
    Ates A; Karaaslan Y; Karatayli E; Ertuğrul E; Aksaray S; Türkyilmaz A; Ozet G
    Tissue Antigens; 2011 Jul; 78(1):56-9. PubMed ID: 21506938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
    Johansson M; Arlestig L; Hallmans G; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2006; 8(1):R19. PubMed ID: 16507117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
    Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
    Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
    Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2007 Aug; 8():54. PubMed ID: 17697317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico.
    Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF
    Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis.
    Sfar I; Dhaouadi T; Habibi I; Abdelmoula L; Makhlouf M; Ben Romdhane T; Jendoubi-Ayed S; Aouadi H; Ben Abdallah T; Ayed K; Zouari R; Lakhoua-Gorgi Y
    Arch Inst Pasteur Tunis; 2009; 86(1-4):51-62. PubMed ID: 20707220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material.
    Viken MK; Olsson M; Flåm ST; Førre O; Kvien TK; Thorsby E; Lie BA
    Tissue Antigens; 2007 Sep; 70(3):190-7. PubMed ID: 17661906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis.
    Burkhardt H; Hüffmeier U; Spriewald B; Böhm B; Rau R; Kallert S; Engström A; Holmdahl R; Reis A
    Arthritis Rheum; 2006 Jan; 54(1):82-9. PubMed ID: 16385499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.